| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.093 | 0.07 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.098 | 0.08 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.084 | 0.09 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.088 | 0.09 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.085 | 0.09 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.081 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.056 | 0.3 |